Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-004-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
The adminstration of 12000 ppm (approximately 1080 mg/kg/d) of the read-across substance DEHA in diet led to a reduction in female parent bodyweight gain during pregnancy and a reduction in offspring weight gain and litter size. No other reproductive parameters were affected and, in particular, there were no effects on fertility in either sex. Also were seen increased liver weights at 12000 ppm (approximately 1080 mg/kg/d) in male and female parents. The NOAEL for this study is ca. 170 mg/kg bw/d.
Link to relevant study records
- Endpoint:
- one-generation reproductive toxicity
- Remarks:
- based on test guideline
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Please see Analogue Approach
- Reason / purpose for cross-reference:
- read-across source
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- no effects observed
- Other effects:
- effects observed, treatment-related
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
- Key result
- Dose descriptor:
- LOAEL
- Effect level:
- 1 080 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Remarks:
- no remarks
- Sex:
- male/female
- Basis for effect level:
- other: increased absolute liver weights, and reduced body weight gain in females
- Remarks on result:
- other: no remarks
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 170 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Remarks:
- no remarks
- Sex:
- male/female
- Basis for effect level:
- other: increased absolute liver weights, and reduced body weight gain in females
- Remarks on result:
- other: no remark
- Key result
- Critical effects observed:
- no
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- no effects observed
- Key result
- Dose descriptor:
- LOAEL
- Generation:
- F1
- Effect level:
- 1 080 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Remarks:
- no remarks
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
- Remarks on result:
- other: no remarks
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- ca. 170 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Mean pup weight gain and total litter weight for both male and female offspring receiving 12000 ppm (1080 mg/kg) DEHA were reduced throughout the whole of the post partum phase (Days 1-36). In addition, mean litter size was slightly reduced at 12000 ppm.
- Remarks on result:
- other: no remarks
- Key result
- Reproductive effects observed:
- no
- Conclusions:
- The adminstration of 12000 ppm (approximately 1080 mg/kg/d) of the read-across substance DEHA in diet led to a reduction in female parent bodyweight gain during pregnancy and a reduction in offspring weight gain and litter size. No other reproductive parameters were affected and, in particular, there where no effects on fertility in either sex. Also were seen increased liver weights at 12000 ppm (approximately 1080 mg/kg/d) in male and female parents. The NOAEL for this study is ca. 170 mg/kg bw/d.
- Executive summary:
The adminstration of 12000 ppm (approximately 1080 mg/kg/d) of the read-across substance DEHA in diet led to a reduction in female parent bodyweight gain during pregnancy and a reduction in offspring weight gain and litter size. No other reproductive parameters were affected and, in particular, there where no effects on fertility in either sex. Also were seen increased liver weights at 12000 ppm (approximately 1080 mg/kg/d) in male and female parents. The NOAEL for this study is ca. 170 mg/kg bw/d.
It is important additionally to note that for the structure "2 -Ethylhexyl" Reproctiontoxicity is one of the most sensitive endpoints and that these effects are considered as unlikely for the Butanedioic acid, 2,3 -dihydroxy-[R-(R*, R*)]-, C12 -13 -branched alkyl esters. Therefore to mention this study and to take these results is "worst case".
Reference
There was a slight increase in food consumption in males dosed with 12000ppm DEHA from 6-10 weeks of the study, the effect being statistically significant at weeks 6-9. Food utilisation was slifghtly less efficients overall for males receiving 12000ppm DEHA.
ORGAN WEIGHTS
An increase in liver weight was observed for both male and female parents receiving 12000ppm DEHA. No other groupp treatment group was effected. This increase in liver weight has been reported previously and is associated with peroxisome proliferation (Moody and Reddy 1978).
Mean pup weight gain and total litter weight for both male and female offspring receiving 12000ppm DEHA were reduced throughout the whole of the post partum phase. There was no effect on either male or female pup weight gain in any other dose group in comparison with the control animals.
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 170 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- Klimisch 2
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
For the reproductive toxicity of Butanedioic acid, 2,3 -dihydroxy-[R-(R*,R*)]-, C12 -13 -branched alkyl esters, no study could be located. Information on reproductive toxicity, available for DEHA as supporting substance, is used for read across.
Reproductive toxicity of DEHA was investigated in a One-generation reproduction toxicity study according to OECD TG 415 (Cefic, 1989). In a 28 day repeated dose toxicity study (OECD TG 407), reproductive organs of male and female animals were examined by necropsy and histopathology. In addition spermatogenesis and oestrous cycling was inspected (Miyata, 2006).
In the One-generation study, a reproductive NOAEL of 170 mg/kg bw/day was determined.
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
No classification for reproductive toxicity is indicated according to the classification, labeling and packaging (CLP) regulation (EC 1272/2008).
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.